Heavy Cannabis Users: Subjective High and Psychomotor Tests Did Not Move Together

Heavy cannabis users can report a substantial high while showing comparatively modest changes on selected psychomotor tests. That dissociation does not establish unimpaired driving or a universal tolerance exemption.

What the experiment measured

Ten chronic cannabis smokers completed controlled smoking sessions with serial whole-blood THC measurements and subjective, physiological and psychomotor assessments. Nine participants were men. The study involved a specified cigarette, rather than today’s entire range of cannabis products.

The researchers compared the timing of reported effects with concentrations collected at the same assessment points. Whole blood was the stated matrix; those values should not be substituted with plasma concentrations from unrelated experiments.

Positive and null responses coexisted

Smoking significantly increased ratings including high, good drug effect, stoned and sedation. Anxiety and restlessness did not significantly change. The authors characterized psychomotor changes as modest relative to the robust subjective and cardiovascular responses.

A null anxiety rating therefore did not mean no intoxication, and a modest task effect did not erase a strong reported high. Different endpoints capture different aspects of response.

Timing complicated the concentration relationship

Blood THC declined rapidly while subjective effects persisted. Mean concentration–effect plots formed counterclockwise hysteresis loops, and individual plots varied substantially.

The same concentration on different portions of a time course can therefore coexist with different effects. A group-average loop does not provide an exact individual reconstruction of time since smoking or functional condition.

How far tolerance evidence travels

The small, selected group limits generalization to occasional users, women and other dosing patterns. Selected laboratory tasks are not equivalent to a complete on-road assessment or collision-risk estimate.

The study supports separating use history, subjective experience, task performance and measured concentration. It does not establish that heavy users are always unaffected, or that subjective high alone supplies an objective measure of every ability relevant to driving.

For context, see our discussion of THC concentrations and the separate question of impairment.

Primary research

David M. Schwope and colleagues. Psychomotor Performance, Subjective and Physiological Effects and Whole Blood Δ9-Tetrahydrocannabinol Concentrations in Heavy, Chronic Cannabis Smokers Following Acute Smoked Cannabis. Journal of Analytical Toxicology (2012). DOI: 10.1093/jat/bks044.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Oral THC Affected Cognition Without a Parallel Symptom-Scale Increase in a Schizophrenia Study

An oral THC condition worsened selected cognitive outcomes without a significant parallel increase in measured psychotic symptoms several hours later. That combination of findings does not show that THC is harmless in schizophrenia or that all routes have identical effects. Several populations and treatment conditions The double-dummy laboratory study involved…

Spread the love

Read Article: Oral THC Affected Cognition Without a Parallel Symptom-Scale Increase in a Schizophrenia Study

CBD-Associated Liver Enzyme Elevations Occurred Without Reported Liver Symptoms

Healthy adults developed elevated liver enzymes during a four-week CBD trial despite not reporting corresponding liver-related symptoms. The finding shows why the absence of symptoms cannot substitute for the laboratory endpoint being studied. A repeated-dose randomized trial The trial involved 201 healthy participants overall and compared CBD at 5 mg/kg…

Spread the love

Read Article: CBD-Associated Liver Enzyme Elevations Occurred Without Reported Liver Symptoms

CBD–Terpene Sleep Trial: The Average Effect Was Smaller Than the Best-Responder Result

A CBD–terpene trial found a small average change in wearable-estimated sleep stages, while the largest reported improvements occurred in selected responders. Those responder figures should not be presented as the expected benefit for everyone with insomnia. A combined formulation and incomplete datasets The study used 300 mg CBD with eight…

Spread the love

Read Article: CBD–Terpene Sleep Trial: The Average Effect Was Smaller Than the Best-Responder Result

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us